Jo Craig

Jo Craig is Senior Vice President CMC for NeRRe Therapeutics and uses her extensive experience, expertise and leadership to ensure delivery of the chemistry, manufacturing and controls (CMC) for Orvepitant through external development and supply organizations. Jo previously held the same role for KaNDy Therapeutics, a Women’s Health company, which was acquired by Bayer Pharmaceuticals in September 2020.